Impact of Pegcetacoplan on Paroxysmal Nocturnal Hemoglobinuria Symptoms in Patients Previously Treated with C5-Inhibitors
Year: 2022
Type: article
Study design: Observational Study
Source: Blood
Authors: Dharmik Desai, Nandini Hadker, Matthew O'Hara, Laura Hill, Jed Perler, David Dingli
Institutions: Apellis Pharmaceuticals (United States), Mayo Clinic
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4310102718